BIXT

$0.02-2.77%visit website

BIOXYTRAN, INC

Market Cap

$2M

Live price × SEC shares (Aug 14, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

1.84

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Research & development	0	2	225	255	483
Total operating expenses	496	607	1,933	655	3,691
Operating income	(496)	(607)	(1,933)	(655)	(3,691)
Interest expense	37	37	36	36	145
Pretax income	(283)	(522)	(2,069)	(620)	(3,494)
Net income	(283)	(522)	(2,069)	(620)	(3,494)
EPS (basic) ($)	0.00		(0.02)	(0.01)	(0.03)
EPS (diluted) ($)	0.00		(0.02)	(0.01)	(0.03)
Weighted avg. shares (basic)	88,992		112,283	114,356
Weighted avg. shares (diluted)	88,992		112,283	114,356

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 14, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

8 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Aug 11, 2026 accepted 7:00 AM ET	8.01Other events	Document SEC ↗
Mar 20, 2026 accepted 9:05 AM ET	3.02Unregistered equity sale8.01Other events	Document SEC ↗
Mar 13, 2026 accepted 4:00 PM ET	3.03Holder rights modified5.02Officer / director change5.03Bylaws / fiscal year	Document SEC ↗
Mar 2, 2026 accepted 9:22 AM ET	8.01Other events	Document SEC ↗
Feb 17, 2026 accepted 6:20 AM ET	1.01Material agreement8.01Other events	Document SEC ↗
Feb 11, 2026 accepted 6:04 AM ET	8.01Other events	Document SEC ↗
Jan 5, 2026 accepted 5:01 PM ET	5.02Officer / director change	Document SEC ↗
Dec 15, 2025 accepted 6:15 AM ET	5.02Officer / director change	Document SEC ↗
Apr 3, 2025 accepted 5:03 PM ET	8-K/A 1.01Material agreement7.01Reg FD disclosure	Document SEC ↗
Jan 22, 2025 accepted 6:05 AM ET	1.01Material agreement8.01Other events	Document SEC ↗